Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings

Developmental Medicine and Child Neurology

Volumn 57, Issue 4, 2015, Pages 385-392

  Pierpont, Elizabeth I ^a   Tworog Dube, Erica ^b   Roberts, Amy E ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CHILD BEHAVIOR CHECKLIST; CLINICAL ARTICLE; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL DISEASE; HUMAN; INTELLECTUAL ASSESSMENT; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MALE; NOONAN SYNDROME; PARENT; PRIORITY JOURNAL; SELF MONITORING; SIBLING; SOCIAL ADAPTATION; SYMPTOMATOLOGY; WECHSLER INTELLIGENCE SCALE; WORKING MEMORY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COHORT ANALYSIS; COMORBIDITY; GENETICS; INTELLIGENCE; PHYSIOLOGY;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COHORT STUDIES; COMORBIDITY; EXECUTIVE FUNCTION; FEMALE; HUMANS; INTELLIGENCE; MALE; NOONAN SYNDROME; SIBLINGS;

EID: 84925114355     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12621     Document Type: Article

References (27)

1. Cesarini L, Alfieri P, Pantaleoni F, Vasta I, Cerutti M, Petrangeli V, et al. Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade. Am J Med Genet A 2009; 149A: 140-6.
2. Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005; 65: 1037-44.
3. Samuels IS, Saitta SC, Landreth GE. MAP'ing CNS development and cognition: an ERKsome process. Neuron 2009; 61: 160-7.
4. Shilyansky C, Karlsgodt KH, Cummings DM, Sidiropoulou K, Hardt M, James AS, et al. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci USA 2010; 107: 13141-6.
5. Mendez HM, Opitz JM. Noonan syndrome: a review. Am J Med Genet 1985; 21: 493-506.
6. Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 2011; 25: 161-79.
7. Pierpont EI, Ellis WS, Roberts AE, Tworog-Dube E, Pierpont ME, Mendelsohn NJ, et al. The language phenotype of children and adolescents with Noonan syndrome. J Speech Lang Hear Res 2010; 53: 917-32.
8. Pierpont EI, Tworog-Dube E, Roberts AE. Learning and memory in children with Noonan syndrome. Am J Med Genet A 2013; 161: 2250-7.
9. Horiguchi T, Takeshita K. Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment. Brain Dev 2003; 25: 291-3.
10. Wood A, Massarano A, Super M, Harrington R. Behavioral aspects and psychiatric findings in Noonan's syndrome. Arch Dis Child 1995; 72: 153-5.
11. Neri G, Allanson J, Kavamura MI. No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes. J Med Genet 2008; 45: 832.
12. Kover ST, Atwood AK. Establishing equivalence: methodological progress in group-matching design and analysis. Am J Intellect Dev Disabil 2013; 118: 3-15.
13. Wechsler D. Wechsler Abbreviated Scale of Intelligence. San Antonio: Pearson, 1999.
14. Manly T, Robertson I, Anderson V, Nimmo-Smith I. Test of Everyday Attention for Children (TEA-Ch). Bury St. Edmunds: Thames Valley Test Company, 1999.
15. Heaton SC, Reader SK, Preston AS, Fennell EB, Puyana OE, Gill N, et al. The Test of Everyday Attention for Children (TEA-Ch): patterns of performance in children with ADHD and clinical controls. Child Neuropsychol 2001; 7: 251-64.
16. Manly T, Anderson V, Nimmo-Smith I, Turner A, Watson P, Robertson IH. The differential assessment of children's attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. J Child Psychol Psychiatry 2001; 42: 1065-81.
17. DuPaul G, Power T, Anastopoulos A, Reid R. ADHD Rating Scale IV. New York: The Guilford Press, 1998.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn. Arlington, VA: American Psychiatric Publishing, 2013.
19. Achenbach T, Rescorla L. Manual for the ASEBA School-Age Form & Profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth, & Families, 2001.
20. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Lutz, FL: Psychological Assessment Resources, 2000.
21. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
22. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Hillsdale, NJ: Erlbaum, 1988.
23. Visser S, Danielson M, Bitsko R, Holbrook J, Kogan M, Ghandour R, et al. Trends in the parent-report of health care provider-diagnosed and medicated ADHD: United States, 2003-2011. J Am Acad Child Adolesc Psychiatry 2014; 53: 34-46.
24. Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health 2010; 46: 209-17.
25. Pelham WE Jr, Fabiano GA, Massetti GM. Evidence-based assessment of attention deficit hyperactivity disorder in children and adolescents. J Clin Child Adolesc Psychol 2005; 34: 449-76.
26. Frazier TW, Demaree HA, Youngstrom EA. Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology 2004; 18: 543-55.
27. Mautner VF, Kluwe L, Thakker SD, Leark RA. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol 2002; 44: 164-70.